Advertisement

The Genetic Basis of Cancer

  • Fred Bunz
Chapter

Abstract

The human body is composed of about 200 different types of cells that organize into a multitude of tissues. Cancers can arise from nearly all of these cell populations. What we casually refer to as cancer is actually a diverse spectrum of human diseases. The most common cancers in adults are carcinomas, derived from epithelial cells that line body cavities and glands. Sarcomas arise from the mesenchymal tissues that form the connective tissues of the body. Melanomas, retinoblastomas, neuroblastomas and glioblastomas are derived from dividing cells in the ocular retina, immature peripheral neurons and neural support cells known as glia, respectively. Lymphomas and leukemias, sometimes referred to as the ‘liquid tumors’, arise in the tissues that give rise to lymphoid and blood cells. All of these diseases will be collectively referred to as ‘cancer’ throughout this book. The rationale for this simplification is that all of these diverse diseases have a single root cause.

Keywords

Cancer Stem Cell Somatic Mutation Adenomatous Polyposis Coli Colorectal Tumor Cancer Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Reading

  1. Antonarakis SE, Krawczak M, Cooper DN (2000) Disease-causing mutations in the human genome. Eur J Pediatr 159(Suppl 3):S173–S178CrossRefPubMedGoogle Scholar
  2. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867CrossRefPubMedPubMedCentralGoogle Scholar
  3. De Marzo AM et al (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7:256–269CrossRefPubMedPubMedCentralGoogle Scholar
  4. Fearnhead NS, Wilding JL, Bodmer WF (2002) Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 64:27–43CrossRefPubMedGoogle Scholar
  5. Fearon ER (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278:1043–1050CrossRefPubMedGoogle Scholar
  6. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767CrossRefPubMedGoogle Scholar
  7. Gatenby RA, Vincent TL (2003) An evolutionary model of carcinogenesis. Cancer Res 63:6212–6220PubMedGoogle Scholar
  8. Haber DA, Settleman J (2007) Cancer: drivers and passengers. Nature 446:145–146CrossRefPubMedGoogle Scholar
  9. Hollstein M et al (1999) New approaches to understanding p53 gene tumor mutation spectra. Mutat Res 431:199–209CrossRefPubMedGoogle Scholar
  10. Kamp DW, Weitzman SA (1999) The molecular basis of asbestos induced lung injury. Thorax 54:638–652CrossRefPubMedPubMedCentralGoogle Scholar
  11. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317:337CrossRefPubMedGoogle Scholar
  12. Klein CA (2006) Random mutations, selected mutations: a PIN opens the door to new genetic landscapes. Proc Natl Acad Sci U S A 103:18033–18034CrossRefPubMedPubMedCentralGoogle Scholar
  13. Lynch M (2010) Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A 107:961–968CrossRefPubMedPubMedCentralGoogle Scholar
  14. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924–935CrossRefPubMedGoogle Scholar
  15. Modica-Napolitano JS, Kulawiec M, Singh KK (2007) Mitochondria and human cancer. Curr Mol Med 7:121–131CrossRefPubMedGoogle Scholar
  16. Nowell PC, Rowley JD, Knudson AG Jr (1998) Cancer genetics, cytogenetics--defining the enemy within. Nat Med 4:1107–1111CrossRefPubMedGoogle Scholar
  17. Salk JJ, Fox EJ, Loeb LA (2010) Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol 5:51–75CrossRefPubMedPubMedCentralGoogle Scholar
  18. Scadden DT (2004) Cancer stem cells refined. Nat Immunol 5:701–703CrossRefPubMedGoogle Scholar
  19. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ (2007) Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 244:703–713CrossRefPubMedGoogle Scholar
  20. Smela ME, Currier SS, Bailey EA, Essigmann JM (2001) The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 22:535–545CrossRefPubMedGoogle Scholar
  21. Spencer SL et al (2006) Modeling somatic evolution in tumorigenesis. PLoS Comput Biol 2:e108CrossRefPubMedPubMedCentralGoogle Scholar
  22. Stein LD (2004) Human genome: end of the beginning. Nature 431:915–916CrossRefPubMedGoogle Scholar
  23. Tomasetti C, Vogelstein B (2015) Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347:78–81CrossRefPubMedPubMedCentralGoogle Scholar
  24. Vaux DL (2011) In defense of the somatic mutation theory of cancer. Bioessays 33:341–343CrossRefPubMedGoogle Scholar
  25. Weinberg RA (1996) How cancer arises. Sci Am 275:62–70CrossRefPubMedGoogle Scholar
  26. Wu S, Powers S, Zhu W, Hannun YA (2016) Substantial contribution of extrinsic risk factors to cancer development. Nature 529:43–47Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2016

Authors and Affiliations

  • Fred Bunz
    • 1
  1. 1.The Johns Hopkins UniversityBaltimoreUSA

Personalised recommendations